Concepts (296)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Surface Plasmon Resonance | 6 | 2021 | 42 | 1.970 |
Why?
|
| Biosensing Techniques | 7 | 2021 | 136 | 1.870 |
Why?
|
| Nucleic Acid Amplification Techniques | 5 | 2021 | 40 | 1.700 |
Why?
|
| Colorimetry | 4 | 2016 | 53 | 1.030 |
Why?
|
| Randomized Controlled Trials as Topic | 6 | 2026 | 375 | 0.970 |
Why?
|
| Models, Statistical | 2 | 2021 | 195 | 0.950 |
Why?
|
| DNA | 4 | 2021 | 592 | 0.940 |
Why?
|
| Metal Nanoparticles | 3 | 2016 | 230 | 0.850 |
Why?
|
| Clubfoot | 1 | 2023 | 2 | 0.840 |
Why?
|
| Gold | 4 | 2021 | 156 | 0.790 |
Why?
|
| Proteins | 2 | 2016 | 382 | 0.780 |
Why?
|
| Tomography | 1 | 2021 | 9 | 0.720 |
Why?
|
| Aptamers, Nucleotide | 3 | 2021 | 51 | 0.680 |
Why?
|
| Nucleic Acid Hybridization | 1 | 2021 | 70 | 0.680 |
Why?
|
| Heart Arrest | 3 | 2015 | 52 | 0.650 |
Why?
|
| Cross-Over Studies | 2 | 2021 | 115 | 0.610 |
Why?
|
| Fractures, Bone | 3 | 2025 | 63 | 0.610 |
Why?
|
| Electrocardiography | 4 | 2015 | 185 | 0.610 |
Why?
|
| DNA, Complementary | 2 | 2020 | 196 | 0.590 |
Why?
|
| Coronavirus Infections | 1 | 2020 | 83 | 0.570 |
Why?
|
| Pneumonia, Viral | 1 | 2020 | 88 | 0.560 |
Why?
|
| Ventricular Fibrillation | 3 | 2014 | 10 | 0.550 |
Why?
|
| Urinary Bladder, Overactive | 1 | 2016 | 3 | 0.510 |
Why?
|
| Urinalysis | 1 | 2017 | 34 | 0.510 |
Why?
|
| Kidney Tubules | 1 | 2017 | 39 | 0.500 |
Why?
|
| Optical Fibers | 1 | 2016 | 8 | 0.490 |
Why?
|
| Erythrocytes | 1 | 2017 | 126 | 0.480 |
Why?
|
| Influenza A virus | 1 | 2016 | 31 | 0.480 |
Why?
|
| Limit of Detection | 4 | 2021 | 94 | 0.470 |
Why?
|
| Mass Screening | 1 | 2020 | 541 | 0.470 |
Why?
|
| Humans | 39 | 2026 | 43102 | 0.460 |
Why?
|
| Humeral Fractures | 2 | 2025 | 3 | 0.450 |
Why?
|
| Osteogenesis Imperfecta | 2 | 2025 | 6 | 0.440 |
Why?
|
| Hepacivirus | 1 | 2015 | 74 | 0.430 |
Why?
|
| Monitoring, Physiologic | 1 | 2014 | 39 | 0.430 |
Why?
|
| Immunoglobulin E | 1 | 2014 | 61 | 0.420 |
Why?
|
| Fracture Fixation, Internal | 4 | 2025 | 13 | 0.420 |
Why?
|
| Treatment Outcome | 7 | 2023 | 1604 | 0.410 |
Why?
|
| Fluorescent Dyes | 1 | 2015 | 182 | 0.410 |
Why?
|
| Epithelial Cells | 1 | 2017 | 434 | 0.400 |
Why?
|
| Odds Ratio | 1 | 2015 | 587 | 0.400 |
Why?
|
| Tachycardia, Ventricular | 1 | 2013 | 15 | 0.390 |
Why?
|
| Attention Deficit Disorder with Hyperactivity | 1 | 2016 | 298 | 0.380 |
Why?
|
| Polycarboxylate Cement | 1 | 2011 | 1 | 0.370 |
Why?
|
| Hepatitis B virus | 1 | 2011 | 18 | 0.360 |
Why?
|
| Electric Stimulation Therapy | 2 | 2026 | 18 | 0.360 |
Why?
|
| Child | 10 | 2026 | 3443 | 0.320 |
Why?
|
| Stomach Neoplasms | 2 | 2023 | 241 | 0.320 |
Why?
|
| DNA, Viral | 1 | 2011 | 311 | 0.320 |
Why?
|
| Health Promotion | 2 | 2026 | 704 | 0.300 |
Why?
|
| Retrospective Studies | 8 | 2023 | 2544 | 0.270 |
Why?
|
| Flatfoot | 1 | 2026 | 1 | 0.250 |
Why?
|
| Bone Nails | 4 | 2025 | 7 | 0.250 |
Why?
|
| Female | 18 | 2026 | 24698 | 0.250 |
Why?
|
| Reactive Oxygen Species | 1 | 2009 | 532 | 0.240 |
Why?
|
| Exercise Therapy | 1 | 2026 | 87 | 0.230 |
Why?
|
| Telemetry | 2 | 2015 | 14 | 0.230 |
Why?
|
| Burns | 1 | 2005 | 10 | 0.230 |
Why?
|
| Male | 18 | 2026 | 23409 | 0.220 |
Why?
|
| Diphosphonates | 1 | 2025 | 19 | 0.220 |
Why?
|
| Bone Density Conservation Agents | 1 | 2025 | 28 | 0.220 |
Why?
|
| Data Interpretation, Statistical | 1 | 2005 | 125 | 0.220 |
Why?
|
| Bone Density | 1 | 2025 | 103 | 0.210 |
Why?
|
| Anti-Retroviral Agents | 1 | 2025 | 160 | 0.210 |
Why?
|
| Wound Healing | 1 | 2005 | 88 | 0.210 |
Why?
|
| Tendon Transfer | 1 | 2023 | 1 | 0.210 |
Why?
|
| Casts, Surgical | 1 | 2023 | 3 | 0.210 |
Why?
|
| Nanostructures | 1 | 2006 | 161 | 0.200 |
Why?
|
| Heart Rate | 2 | 2015 | 266 | 0.200 |
Why?
|
| Medication Adherence | 1 | 2025 | 182 | 0.200 |
Why?
|
| Radius Fractures | 1 | 2023 | 4 | 0.200 |
Why?
|
| Rats, Sprague-Dawley | 4 | 2017 | 1766 | 0.200 |
Why?
|
| Vaccination | 1 | 2026 | 355 | 0.200 |
Why?
|
| Disease Models, Animal | 5 | 2017 | 1596 | 0.200 |
Why?
|
| HIV Infections | 3 | 2025 | 2586 | 0.200 |
Why?
|
| Adolescent | 9 | 2025 | 6081 | 0.190 |
Why?
|
| Databases, Factual | 1 | 2024 | 341 | 0.190 |
Why?
|
| Helicobacter Infections | 1 | 2022 | 86 | 0.180 |
Why?
|
| Alcohol Drinking | 2 | 2025 | 609 | 0.180 |
Why?
|
| Textiles | 1 | 2021 | 7 | 0.180 |
Why?
|
| Electric Impedance | 1 | 2021 | 28 | 0.180 |
Why?
|
| Alcoholism | 1 | 2025 | 305 | 0.180 |
Why?
|
| Helicobacter pylori | 1 | 2022 | 118 | 0.180 |
Why?
|
| Taiwan | 2 | 2024 | 23 | 0.180 |
Why?
|
| Electrodes | 1 | 2021 | 59 | 0.180 |
Why?
|
| Monte Carlo Method | 1 | 2021 | 64 | 0.180 |
Why?
|
| Polymerase Chain Reaction | 2 | 2020 | 455 | 0.170 |
Why?
|
| Middle Aged | 11 | 2025 | 12222 | 0.170 |
Why?
|
| Rats | 4 | 2017 | 3735 | 0.160 |
Why?
|
| Ribonuclease P | 1 | 2020 | 2 | 0.160 |
Why?
|
| Adult | 13 | 2026 | 13872 | 0.160 |
Why?
|
| Animals | 9 | 2017 | 16992 | 0.160 |
Why?
|
| Microbial Viability | 2 | 2016 | 42 | 0.160 |
Why?
|
| Certification | 1 | 2020 | 21 | 0.160 |
Why?
|
| Voice Disorders | 1 | 2018 | 1 | 0.150 |
Why?
|
| Child, Preschool | 3 | 2024 | 1546 | 0.140 |
Why?
|
| Incidence | 2 | 2024 | 1078 | 0.140 |
Why?
|
| Algorithms | 3 | 2021 | 509 | 0.140 |
Why?
|
| Computer Simulation | 1 | 2020 | 408 | 0.140 |
Why?
|
| Bone Screws | 2 | 2023 | 8 | 0.130 |
Why?
|
| Refractometry | 2 | 2021 | 16 | 0.130 |
Why?
|
| Centrifugation | 1 | 2017 | 7 | 0.130 |
Why?
|
| Equipment Design | 2 | 2021 | 145 | 0.130 |
Why?
|
| Myocardial Infarction | 1 | 2020 | 247 | 0.130 |
Why?
|
| Risk Factors | 2 | 2016 | 3994 | 0.130 |
Why?
|
| Acetic Acid | 1 | 2016 | 19 | 0.130 |
Why?
|
| Escherichia coli O157 | 1 | 2016 | 17 | 0.130 |
Why?
|
| Longitudinal Studies | 2 | 2020 | 1063 | 0.130 |
Why?
|
| Orthopedics | 1 | 2016 | 8 | 0.120 |
Why?
|
| Neuralgia | 1 | 2017 | 22 | 0.120 |
Why?
|
| Cryopreservation | 1 | 2016 | 39 | 0.120 |
Why?
|
| Anti-HIV Agents | 1 | 2021 | 486 | 0.120 |
Why?
|
| Bacterial Toxins | 1 | 2016 | 50 | 0.120 |
Why?
|
| Outpatients | 1 | 2016 | 37 | 0.120 |
Why?
|
| Heart Conduction System | 2 | 2014 | 15 | 0.120 |
Why?
|
| Influenza in Birds | 1 | 2016 | 11 | 0.120 |
Why?
|
| Antigens, Viral | 1 | 2016 | 48 | 0.120 |
Why?
|
| Aged | 7 | 2018 | 8214 | 0.120 |
Why?
|
| Urethra | 1 | 2015 | 3 | 0.120 |
Why?
|
| Urination Disorders | 1 | 2015 | 4 | 0.120 |
Why?
|
| DNA, Single-Stranded | 1 | 2015 | 40 | 0.120 |
Why?
|
| Catalysis | 1 | 2016 | 187 | 0.120 |
Why?
|
| Weather | 1 | 2015 | 13 | 0.120 |
Why?
|
| Flow Cytometry | 1 | 2017 | 411 | 0.120 |
Why?
|
| Dysmenorrhea | 1 | 2015 | 3 | 0.110 |
Why?
|
| Fluorescein | 1 | 2015 | 18 | 0.110 |
Why?
|
| Signal Processing, Computer-Assisted | 1 | 2015 | 66 | 0.110 |
Why?
|
| Birds | 1 | 2016 | 96 | 0.110 |
Why?
|
| Brugada Syndrome | 1 | 2014 | 2 | 0.110 |
Why?
|
| Serotonin | 1 | 2015 | 123 | 0.110 |
Why?
|
| Spinal Cord Injuries | 1 | 2015 | 69 | 0.110 |
Why?
|
| Sleep Apnea, Obstructive | 1 | 2015 | 57 | 0.110 |
Why?
|
| Cardiopulmonary Resuscitation | 1 | 2014 | 24 | 0.110 |
Why?
|
| Biofilms | 1 | 2016 | 184 | 0.110 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2016 | 458 | 0.110 |
Why?
|
| Analgesics | 1 | 2015 | 55 | 0.110 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2016 | 652 | 0.110 |
Why?
|
| Infant, Newborn | 2 | 2024 | 972 | 0.110 |
Why?
|
| Dengue Virus | 1 | 2015 | 96 | 0.110 |
Why?
|
| Arrhythmias, Cardiac | 1 | 2014 | 42 | 0.110 |
Why?
|
| Intensive Care Units | 1 | 2014 | 72 | 0.110 |
Why?
|
| Pilot Projects | 3 | 2025 | 760 | 0.110 |
Why?
|
| Electronic Health Records | 1 | 2015 | 108 | 0.110 |
Why?
|
| Young Adult | 6 | 2025 | 5080 | 0.110 |
Why?
|
| Microscopy, Fluorescence | 1 | 2015 | 256 | 0.110 |
Why?
|
| Dengue | 1 | 2015 | 107 | 0.100 |
Why?
|
| Patient Discharge | 1 | 2014 | 128 | 0.100 |
Why?
|
| Nucleic Acid Conformation | 1 | 2014 | 154 | 0.100 |
Why?
|
| RNA, Viral | 1 | 2015 | 321 | 0.100 |
Why?
|
| Nanotechnology | 1 | 2015 | 176 | 0.100 |
Why?
|
| Tourniquets | 1 | 2012 | 1 | 0.100 |
Why?
|
| Soft Tissue Injuries | 1 | 2012 | 1 | 0.100 |
Why?
|
| Stochastic Processes | 1 | 2013 | 10 | 0.100 |
Why?
|
| Linear Models | 2 | 2012 | 317 | 0.100 |
Why?
|
| Arthroplasty, Replacement, Knee | 1 | 2012 | 14 | 0.100 |
Why?
|
| Blood Loss, Surgical | 1 | 2012 | 15 | 0.100 |
Why?
|
| Bacteria | 1 | 2016 | 293 | 0.100 |
Why?
|
| Research Design | 1 | 2015 | 385 | 0.090 |
Why?
|
| Base Sequence | 1 | 2014 | 983 | 0.090 |
Why?
|
| Uganda | 2 | 2025 | 22 | 0.090 |
Why?
|
| Bacterial Proteins | 1 | 2016 | 595 | 0.090 |
Why?
|
| Hepatitis B | 1 | 2011 | 41 | 0.090 |
Why?
|
| Health Services Accessibility | 1 | 2017 | 706 | 0.090 |
Why?
|
| Pain | 1 | 2015 | 290 | 0.090 |
Why?
|
| Soft Tissue Neoplasms | 1 | 2011 | 15 | 0.090 |
Why?
|
| Neoplasm Staging | 2 | 2023 | 374 | 0.090 |
Why?
|
| Musculoskeletal System | 1 | 2011 | 12 | 0.090 |
Why?
|
| Molecular Sequence Data | 1 | 2014 | 1542 | 0.090 |
Why?
|
| Sensitivity and Specificity | 1 | 2013 | 611 | 0.090 |
Why?
|
| Clavicle | 1 | 2010 | 2 | 0.090 |
Why?
|
| Fracture Fixation, Intramedullary | 1 | 2010 | 4 | 0.080 |
Why?
|
| Counseling | 2 | 2025 | 138 | 0.080 |
Why?
|
| Femoral Neck Fractures | 1 | 2010 | 1 | 0.080 |
Why?
|
| Protons | 1 | 2011 | 94 | 0.080 |
Why?
|
| Dichlorodiphenyl Dichloroethylene | 1 | 2010 | 6 | 0.080 |
Why?
|
| Temperature | 1 | 2011 | 313 | 0.080 |
Why?
|
| Likelihood Functions | 1 | 2010 | 62 | 0.080 |
Why?
|
| Magnetic Resonance Spectroscopy | 1 | 2011 | 301 | 0.080 |
Why?
|
| Maternal Exposure | 1 | 2010 | 57 | 0.080 |
Why?
|
| Ethidium | 1 | 2009 | 9 | 0.080 |
Why?
|
| Depression | 1 | 2017 | 863 | 0.080 |
Why?
|
| NADP | 1 | 2009 | 37 | 0.080 |
Why?
|
| Surface Properties | 2 | 2007 | 160 | 0.070 |
Why?
|
| Fluorescence | 1 | 2009 | 118 | 0.070 |
Why?
|
| Analysis of Variance | 1 | 2010 | 575 | 0.070 |
Why?
|
| Premature Birth | 1 | 2010 | 95 | 0.070 |
Why?
|
| Predictive Value of Tests | 2 | 2011 | 440 | 0.070 |
Why?
|
| Dental Bonding | 1 | 2007 | 1 | 0.070 |
Why?
|
| Inlays | 1 | 2007 | 1 | 0.070 |
Why?
|
| Resin Cements | 1 | 2007 | 1 | 0.070 |
Why?
|
| Dentin | 1 | 2007 | 3 | 0.070 |
Why?
|
| Composite Resins | 1 | 2007 | 5 | 0.070 |
Why?
|
| United States | 2 | 2025 | 5205 | 0.060 |
Why?
|
| Microscopy, Electron, Scanning | 2 | 2016 | 159 | 0.060 |
Why?
|
| Orthotic Devices | 1 | 2026 | 5 | 0.060 |
Why?
|
| Silicon Compounds | 1 | 2006 | 7 | 0.060 |
Why?
|
| Glycerophospholipids | 1 | 2025 | 4 | 0.060 |
Why?
|
| Bone Remodeling | 1 | 2025 | 24 | 0.060 |
Why?
|
| Double-Blind Method | 1 | 2026 | 317 | 0.060 |
Why?
|
| Spectrophotometry | 1 | 2005 | 63 | 0.060 |
Why?
|
| Scattering, Radiation | 1 | 2005 | 43 | 0.060 |
Why?
|
| Family Characteristics | 1 | 2025 | 126 | 0.050 |
Why?
|
| Pregnancy | 1 | 2010 | 1772 | 0.050 |
Why?
|
| Ulnar Nerve | 1 | 2023 | 1 | 0.050 |
Why?
|
| Humerus | 1 | 2023 | 4 | 0.050 |
Why?
|
| California | 1 | 2026 | 548 | 0.050 |
Why?
|
| Pharmaceutical Preparations | 1 | 2005 | 94 | 0.050 |
Why?
|
| Sex Distribution | 1 | 2024 | 224 | 0.050 |
Why?
|
| Age Distribution | 1 | 2024 | 249 | 0.050 |
Why?
|
| Cost of Illness | 1 | 2024 | 98 | 0.050 |
Why?
|
| Bone Plates | 1 | 2023 | 4 | 0.050 |
Why?
|
| Ultrasonography | 1 | 2023 | 135 | 0.050 |
Why?
|
| Hypercholesterolemia | 1 | 2003 | 42 | 0.050 |
Why?
|
| Sympathetic Nervous System | 1 | 2003 | 57 | 0.050 |
Why?
|
| Fluorouracil | 1 | 2023 | 47 | 0.050 |
Why?
|
| Length of Stay | 1 | 2024 | 229 | 0.050 |
Why?
|
| Drug Delivery Systems | 1 | 2005 | 277 | 0.050 |
Why?
|
| Ventricular Remodeling | 1 | 2003 | 61 | 0.050 |
Why?
|
| Recurrence | 1 | 2022 | 152 | 0.050 |
Why?
|
| Registries | 1 | 2024 | 437 | 0.040 |
Why?
|
| Motivation | 1 | 2026 | 513 | 0.040 |
Why?
|
| Heart | 1 | 2003 | 184 | 0.040 |
Why?
|
| Aged, 80 and over | 3 | 2015 | 2853 | 0.040 |
Why?
|
| Comorbidity | 1 | 2024 | 737 | 0.040 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2022 | 154 | 0.040 |
Why?
|
| Bayes Theorem | 1 | 2021 | 126 | 0.040 |
Why?
|
| Infant | 1 | 2024 | 1175 | 0.040 |
Why?
|
| Hospitalization | 1 | 2024 | 485 | 0.040 |
Why?
|
| Prognosis | 1 | 2022 | 861 | 0.040 |
Why?
|
| Prevalence | 1 | 2024 | 1612 | 0.040 |
Why?
|
| Glottis | 1 | 2018 | 2 | 0.040 |
Why?
|
| Vocal Cord Paralysis | 1 | 2018 | 2 | 0.040 |
Why?
|
| Voice Quality | 1 | 2018 | 5 | 0.040 |
Why?
|
| Laryngeal Neoplasms | 1 | 2018 | 13 | 0.040 |
Why?
|
| Hospital Mortality | 1 | 2020 | 210 | 0.040 |
Why?
|
| Demography | 1 | 2018 | 195 | 0.030 |
Why?
|
| Reproducibility of Results | 1 | 2021 | 1081 | 0.030 |
Why?
|
| Spinal Nerves | 1 | 2017 | 5 | 0.030 |
Why?
|
| Rural Health Services | 1 | 2017 | 48 | 0.030 |
Why?
|
| Delivery of Health Care | 1 | 2020 | 310 | 0.030 |
Why?
|
| Hyperalgesia | 1 | 2017 | 24 | 0.030 |
Why?
|
| Wounds and Injuries | 1 | 2018 | 193 | 0.030 |
Why?
|
| Food Contamination | 1 | 2016 | 57 | 0.030 |
Why?
|
| Biomass | 1 | 2016 | 68 | 0.030 |
Why?
|
| Referral and Consultation | 1 | 2017 | 142 | 0.030 |
Why?
|
| Sequence Analysis, RNA | 1 | 2016 | 115 | 0.030 |
Why?
|
| DNA, Bacterial | 1 | 2016 | 206 | 0.030 |
Why?
|
| Urination | 1 | 2015 | 3 | 0.030 |
Why?
|
| Urodynamics | 1 | 2015 | 5 | 0.030 |
Why?
|
| Genome, Bacterial | 1 | 2016 | 139 | 0.030 |
Why?
|
| Severity of Illness Index | 1 | 2018 | 719 | 0.030 |
Why?
|
| HIV Seropositivity | 1 | 2017 | 196 | 0.030 |
Why?
|
| Homosexuality, Male | 1 | 2021 | 486 | 0.030 |
Why?
|
| Peru | 1 | 2015 | 41 | 0.030 |
Why?
|
| Gene Expression Regulation, Bacterial | 1 | 2016 | 171 | 0.030 |
Why?
|
| Respiratory System | 1 | 2015 | 31 | 0.030 |
Why?
|
| Electromyography | 1 | 2015 | 69 | 0.030 |
Why?
|
| Age Factors | 1 | 2018 | 1154 | 0.030 |
Why?
|
| Down-Regulation | 1 | 2016 | 456 | 0.030 |
Why?
|
| Sex Factors | 1 | 2018 | 1028 | 0.030 |
Why?
|
| Polymers | 1 | 2016 | 155 | 0.030 |
Why?
|
| Clinical Competence | 1 | 2015 | 156 | 0.030 |
Why?
|
| Up-Regulation | 1 | 2016 | 536 | 0.030 |
Why?
|
| Genotype | 1 | 2016 | 800 | 0.030 |
Why?
|
| Rural Population | 1 | 2017 | 373 | 0.030 |
Why?
|
| Sleep | 1 | 2015 | 185 | 0.030 |
Why?
|
| Hemostasis, Surgical | 1 | 2012 | 2 | 0.020 |
Why?
|
| Hematocrit | 1 | 2012 | 26 | 0.020 |
Why?
|
| Hemoglobins | 1 | 2012 | 113 | 0.020 |
Why?
|
| Mutation | 1 | 2016 | 1177 | 0.020 |
Why?
|
| Smoking | 1 | 2018 | 1024 | 0.020 |
Why?
|
| Shoulder Joint | 1 | 2010 | 4 | 0.020 |
Why?
|
| Range of Motion, Articular | 1 | 2010 | 37 | 0.020 |
Why?
|
| Time Factors | 1 | 2015 | 1857 | 0.020 |
Why?
|
| Prosthesis Design | 1 | 2010 | 47 | 0.020 |
Why?
|
| Radiography | 1 | 2010 | 71 | 0.020 |
Why?
|
| Recovery of Function | 1 | 2010 | 107 | 0.020 |
Why?
|
| Multivariate Analysis | 1 | 2011 | 638 | 0.020 |
Why?
|
| Dental Cavity Preparation | 1 | 2007 | 1 | 0.020 |
Why?
|
| Dentin Permeability | 1 | 2007 | 1 | 0.020 |
Why?
|
| Acid Etching, Dental | 1 | 2007 | 2 | 0.020 |
Why?
|
| Dental Stress Analysis | 1 | 2007 | 5 | 0.020 |
Why?
|
| Lasers, Solid-State | 1 | 2007 | 12 | 0.020 |
Why?
|
| Tensile Strength | 1 | 2007 | 27 | 0.020 |
Why?
|
| Follow-Up Studies | 1 | 2010 | 1067 | 0.020 |
Why?
|
| Cholesterol, Dietary | 1 | 2003 | 9 | 0.010 |
Why?
|
| Electrophysiologic Techniques, Cardiac | 1 | 2003 | 9 | 0.010 |
Why?
|
| GAP-43 Protein | 1 | 2003 | 9 | 0.010 |
Why?
|
| Binding Sites | 1 | 2005 | 671 | 0.010 |
Why?
|
| Tyrosine 3-Monooxygenase | 1 | 2003 | 92 | 0.010 |
Why?
|
| Rabbits | 1 | 2003 | 278 | 0.010 |
Why?
|
| Triglycerides | 1 | 2003 | 147 | 0.010 |
Why?
|
| Disease Susceptibility | 1 | 2003 | 101 | 0.010 |
Why?
|
| Coronary Vessels | 1 | 2003 | 92 | 0.010 |
Why?
|
| Cholesterol | 1 | 2003 | 232 | 0.010 |
Why?
|
| Action Potentials | 1 | 2003 | 246 | 0.010 |
Why?
|